Enviar pesquisa
Carregar
Rare Solid Cancers: An Introduction - Slide 5 - J. Geissler - Patient advocacy groups in rare cancers
•
1 gostou
•
611 visualizações
European School of Oncology
Seguir
Denunciar
Compartilhar
Denunciar
Compartilhar
1 de 20
Recomendados
How to Be Your Best Advocate
How to Be Your Best Advocate
CancerSupportNow
The involvement of patients and survivors in volunteer advocacy survey
The involvement of patients and survivors in volunteer advocacy survey
Canadian Cancer Survivor Network
Virgil Simons
Virgil Simons
Virgil Simons, MPA
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
jangeissler
The value off engaging patients in research
The value off engaging patients in research
Simon Denegri
Neil Formstone
Neil Formstone
BBMRI Stakeholder's Forum
The Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacy
jangeissler
Rare Cancers - How to Empower Patients & Advocacy Organizations through Colla...
Rare Cancers - How to Empower Patients & Advocacy Organizations through Colla...
Canadian Cancer Survivor Network
Recomendados
How to Be Your Best Advocate
How to Be Your Best Advocate
CancerSupportNow
The involvement of patients and survivors in volunteer advocacy survey
The involvement of patients and survivors in volunteer advocacy survey
Canadian Cancer Survivor Network
Virgil Simons
Virgil Simons
Virgil Simons, MPA
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
jangeissler
The value off engaging patients in research
The value off engaging patients in research
Simon Denegri
Neil Formstone
Neil Formstone
BBMRI Stakeholder's Forum
The Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacy
jangeissler
Rare Cancers - How to Empower Patients & Advocacy Organizations through Colla...
Rare Cancers - How to Empower Patients & Advocacy Organizations through Colla...
Canadian Cancer Survivor Network
Personalized Disease Management - Thyroid Cancer - Knowledge Management - Sun...
Personalized Disease Management - Thyroid Cancer - Knowledge Management - Sun...
Sunil Nair
Minorities in-Medicine AAMC
Minorities in-Medicine AAMC
Imhotep Virtual Medical School
The Super Intern
The Super Intern
amaan91
Harald Schmidt: Research data in benefit design
Harald Schmidt: Research data in benefit design
Nuffield Trust
Navigation seminar flyer
Navigation seminar flyer
Toddy Wobbema
Usa health care system
Usa health care system
Elizabeth
The emergence of the e-patient
The emergence of the e-patient
jangeissler
Rehab a.o'rourke
Rehab a.o'rourke
andreafletcher
Setting Normative Function: Identification of areas where Standards and Guide...
Setting Normative Function: Identification of areas where Standards and Guide...
Human Variome Project
Ocumel Ireland - 2019 CURE OM Symposium
Ocumel Ireland - 2019 CURE OM Symposium
Melanoma Research Foundation
Advocacy for Reproductive Health: STFM
Advocacy for Reproductive Health: STFM
Sharon Phillips
Patient-Reported Outcomes in Cancer Care - Zeena Nackerdien
Patient-Reported Outcomes in Cancer Care - Zeena Nackerdien
Zeena Nackerdien
01 wengstrom 1
01 wengstrom 1
pirandelliano
Introduction To Healthcare Organizations 111510
Introduction To Healthcare Organizations 111510
Bethel SDA Church
Care Coordination: Provider and Patient Impact | West Corporation
Care Coordination: Provider and Patient Impact | West Corporation
westcorphealth
CADTH - Why it is important, and what now?
CADTH - Why it is important, and what now?
Canadian Cancer Survivor Network
Presentation - Northern Health Research Conference
Presentation - Northern Health Research Conference
Suzanne McGuire
certwhitepaper-execsummary
certwhitepaper-execsummary
Jared Carter
For Cancer Center and Ins Co consideration v4 2
For Cancer Center and Ins Co consideration v4 2
Zeke Wimert
Advocacy and the cancer patient viewpoint
Advocacy and the cancer patient viewpoint
IMSHealthRWES
Access to treatment, care and clinical trials by patients with rare cancers...
Access to treatment, care and clinical trials by patients with rare cancers...
patvocates
Information and support for patients on MKI treatment
Information and support for patients on MKI treatment
Marika Porrey
Mais conteúdo relacionado
Mais procurados
Personalized Disease Management - Thyroid Cancer - Knowledge Management - Sun...
Personalized Disease Management - Thyroid Cancer - Knowledge Management - Sun...
Sunil Nair
Minorities in-Medicine AAMC
Minorities in-Medicine AAMC
Imhotep Virtual Medical School
The Super Intern
The Super Intern
amaan91
Harald Schmidt: Research data in benefit design
Harald Schmidt: Research data in benefit design
Nuffield Trust
Navigation seminar flyer
Navigation seminar flyer
Toddy Wobbema
Usa health care system
Usa health care system
Elizabeth
The emergence of the e-patient
The emergence of the e-patient
jangeissler
Rehab a.o'rourke
Rehab a.o'rourke
andreafletcher
Setting Normative Function: Identification of areas where Standards and Guide...
Setting Normative Function: Identification of areas where Standards and Guide...
Human Variome Project
Ocumel Ireland - 2019 CURE OM Symposium
Ocumel Ireland - 2019 CURE OM Symposium
Melanoma Research Foundation
Advocacy for Reproductive Health: STFM
Advocacy for Reproductive Health: STFM
Sharon Phillips
Patient-Reported Outcomes in Cancer Care - Zeena Nackerdien
Patient-Reported Outcomes in Cancer Care - Zeena Nackerdien
Zeena Nackerdien
01 wengstrom 1
01 wengstrom 1
pirandelliano
Introduction To Healthcare Organizations 111510
Introduction To Healthcare Organizations 111510
Bethel SDA Church
Care Coordination: Provider and Patient Impact | West Corporation
Care Coordination: Provider and Patient Impact | West Corporation
westcorphealth
CADTH - Why it is important, and what now?
CADTH - Why it is important, and what now?
Canadian Cancer Survivor Network
Presentation - Northern Health Research Conference
Presentation - Northern Health Research Conference
Suzanne McGuire
certwhitepaper-execsummary
certwhitepaper-execsummary
Jared Carter
For Cancer Center and Ins Co consideration v4 2
For Cancer Center and Ins Co consideration v4 2
Zeke Wimert
Mais procurados
(19)
Personalized Disease Management - Thyroid Cancer - Knowledge Management - Sun...
Personalized Disease Management - Thyroid Cancer - Knowledge Management - Sun...
Minorities in-Medicine AAMC
Minorities in-Medicine AAMC
The Super Intern
The Super Intern
Harald Schmidt: Research data in benefit design
Harald Schmidt: Research data in benefit design
Navigation seminar flyer
Navigation seminar flyer
Usa health care system
Usa health care system
The emergence of the e-patient
The emergence of the e-patient
Rehab a.o'rourke
Rehab a.o'rourke
Setting Normative Function: Identification of areas where Standards and Guide...
Setting Normative Function: Identification of areas where Standards and Guide...
Ocumel Ireland - 2019 CURE OM Symposium
Ocumel Ireland - 2019 CURE OM Symposium
Advocacy for Reproductive Health: STFM
Advocacy for Reproductive Health: STFM
Patient-Reported Outcomes in Cancer Care - Zeena Nackerdien
Patient-Reported Outcomes in Cancer Care - Zeena Nackerdien
01 wengstrom 1
01 wengstrom 1
Introduction To Healthcare Organizations 111510
Introduction To Healthcare Organizations 111510
Care Coordination: Provider and Patient Impact | West Corporation
Care Coordination: Provider and Patient Impact | West Corporation
CADTH - Why it is important, and what now?
CADTH - Why it is important, and what now?
Presentation - Northern Health Research Conference
Presentation - Northern Health Research Conference
certwhitepaper-execsummary
certwhitepaper-execsummary
For Cancer Center and Ins Co consideration v4 2
For Cancer Center and Ins Co consideration v4 2
Semelhante a Rare Solid Cancers: An Introduction - Slide 5 - J. Geissler - Patient advocacy groups in rare cancers
Advocacy and the cancer patient viewpoint
Advocacy and the cancer patient viewpoint
IMSHealthRWES
Access to treatment, care and clinical trials by patients with rare cancers...
Access to treatment, care and clinical trials by patients with rare cancers...
patvocates
Information and support for patients on MKI treatment
Information and support for patients on MKI treatment
Marika Porrey
Partnering with Patients: Designing, Participating in and Reporting Health Ou...
Partnering with Patients: Designing, Participating in and Reporting Health Ou...
patvocates
Paula Kim
Paula Kim
BBMRI Stakeholder's Forum
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
patvocates
PowerPoint Presentation +.ppt
PowerPoint Presentation +.ppt
Shaan73
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
jangeissler
How to communicate scientific and medical information to patients, advocates ...
How to communicate scientific and medical information to patients, advocates ...
jangeissler
CSC Insight into Patient Access to Care in Cancer
CSC Insight into Patient Access to Care in Cancer
Bev Soult
The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...
jangeissler
Rare Solid Cancers: An Introduction - Slide 4 - K. Redmond - Information on r...
Rare Solid Cancers: An Introduction - Slide 4 - K. Redmond - Information on r...
European School of Oncology
2010 11 13 european cme forum jan geissler 1.5
2010 11 13 european cme forum jan geissler 1.5
jangeissler
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
jangeissler
CSC
CSC
Michael Szot
Elevating-the-Patient-Voice
Elevating-the-Patient-Voice
Bev Soult
INFORMATION SHARING AND SHARED DECISION MAKING IN CLINICAL .pptx
INFORMATION SHARING AND SHARED DECISION MAKING IN CLINICAL .pptx
Suryansh Agrawal
Patient engagement in clinical trials
Patient engagement in clinical trials
Martin Kelly
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
patvocates
Understanding The Principles Multi-Disciplinary Approach To Cancer Treatment ...
Understanding The Principles Multi-Disciplinary Approach To Cancer Treatment ...
flasco_org
Semelhante a Rare Solid Cancers: An Introduction - Slide 5 - J. Geissler - Patient advocacy groups in rare cancers
(20)
Advocacy and the cancer patient viewpoint
Advocacy and the cancer patient viewpoint
Access to treatment, care and clinical trials by patients with rare cancers...
Access to treatment, care and clinical trials by patients with rare cancers...
Information and support for patients on MKI treatment
Information and support for patients on MKI treatment
Partnering with Patients: Designing, Participating in and Reporting Health Ou...
Partnering with Patients: Designing, Participating in and Reporting Health Ou...
Paula Kim
Paula Kim
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
PowerPoint Presentation +.ppt
PowerPoint Presentation +.ppt
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
How to communicate scientific and medical information to patients, advocates ...
How to communicate scientific and medical information to patients, advocates ...
CSC Insight into Patient Access to Care in Cancer
CSC Insight into Patient Access to Care in Cancer
The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...
Rare Solid Cancers: An Introduction - Slide 4 - K. Redmond - Information on r...
Rare Solid Cancers: An Introduction - Slide 4 - K. Redmond - Information on r...
2010 11 13 european cme forum jan geissler 1.5
2010 11 13 european cme forum jan geissler 1.5
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
CSC
CSC
Elevating-the-Patient-Voice
Elevating-the-Patient-Voice
INFORMATION SHARING AND SHARED DECISION MAKING IN CLINICAL .pptx
INFORMATION SHARING AND SHARED DECISION MAKING IN CLINICAL .pptx
Patient engagement in clinical trials
Patient engagement in clinical trials
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Understanding The Principles Multi-Disciplinary Approach To Cancer Treatment ...
Understanding The Principles Multi-Disciplinary Approach To Cancer Treatment ...
Mais de European School of Oncology
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
European School of Oncology
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
European School of Oncology
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
European School of Oncology
W. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - Guidelines
European School of Oncology
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomas
European School of Oncology
H. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the art
European School of Oncology
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
European School of Oncology
1 azim
1 azim
European School of Oncology
H. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the art
European School of Oncology
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccine
European School of Oncology
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
European School of Oncology
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the art
European School of Oncology
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
European School of Oncology
V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art
European School of Oncology
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer
European School of Oncology
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancer
European School of Oncology
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the art
European School of Oncology
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
European School of Oncology
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the art
European School of Oncology
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
European School of Oncology
Mais de European School of Oncology
(20)
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
W. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - Guidelines
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomas
H. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the art
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
1 azim
1 azim
H. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the art
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccine
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the art
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancer
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the art
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
Rare Solid Cancers: An Introduction - Slide 5 - J. Geissler - Patient advocacy groups in rare cancers
1.
Patient
advocacy groups in rare cancers Jan Geissler Co-founder, CML Advocates Network Chair, LeukaNET Founder, Patvocates http://www.cmladvocates.net
2.
3.
4.
5.
6.
7.
8.
Role #1
Patient Information and Support
9.
10.
11.
12.
Role #2
Influencing the political agenda
13.
14.
Role #3
Patients' participation in (rare) cancer research
15.
16.
17.
18.
19.
20.